Acute and Long Term Effects of 1‐Methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP) in Tests of Nociception in Mice

Pharmacology & Toxicology

Volumn 70, Issue 1, 1992, Pages 31-37

  Rosland, Jan Henrik ^a   Hunskaar, Steinar ^a   Broch, Ole Jacob ^a   Hole, Kjell ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CHRONIC TOXICITY; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; MALE; MOUSE; NOCICEPTION; NONHUMAN; TOXICITY;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMAL; DRUG ADMINISTRATION SCHEDULE; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED STRAINS; PAIN; PAIN MEASUREMENT; SUPPORT, NON-U.S. GOV'T;

EID: 0026528986     PISSN: 09019928     EISSN: 16000773     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1992.tb00421.x     Document Type: Article

References (39)

1. Time course of changes in nociception of 5, 6‐dihydroxytryptamine lesions of descending 5‐HT pathways
2. Acute ipsilateral hyperalgesia and chronic contralateral hypoalgesia after unilateral 6‐hydroxydopamine lesions of the substantia nigra
3. Apparent hyperalgesia in the mouse tail‐flick test due to increased tail skin temperature after lesioning of serotonergic pathways
4. 5‐HT depletion with 5, 7‐DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5‐MeODMT, 8‐OH‐DPAT and 5‐HTP as measured by two nociceptive tests
5. The role of tail skin temperature in the facilitation of the tail‐flick reflex after spinal transection or interference with descending serotonergic neurotransmission
6. Effect of central catecholamine depletions by 6‐hydroxydopamine on morphine antinociception in rats
7. Changes in nociception after intrathecal administration of 5, 6‐dihydroxytryptamine in mice
8. Monoamines and descending control of nociception
9. MPTP alters central catecholamine neurons in addition to the nigrostriatal system
10. Treatment with GM1 ganglioside restores striatal dopamine in the 1‐methyl‐4–phenyl‐1, 2, 3, 6‐tetrahydropyridine‐treated mouse
11. Reversible serotonergic neurotoxicity of N‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP) in mouse striatum studied by neurochemical and immunohistochemical approaches
12. Dopaminergic neurotoxicity of 1‐methyl‐4‐phenyl‐1, 2, 5, 6‐tetrahydropyridine in mice
13. Differential neurotoxicity of 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP) in Swiss‐Webster mice from different sources
14. Some features of the nigrostriatal dopaminergic neurotoxin 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP) in the mouse
15. Changes in sensitivity to intrathecal norepinephrine and serotonin after 6‐hydroxydopamine (6‐OHDA), 5, 6‐dihydroxytryptamine (5, 6‐DHT) or repeated monoamine administration
16. Formalin test in mice, a useful technique for evaluating mild analgesics
17. A modified hot‐plate test sensitive to mild analgesics
18. Mechanisms of orphenadrine‐induced antinociception in mice: a role for serotonergic pathways
19. Effects of an intrathecal dopamine agonist, apomorphine, on thermal and chemical evoked noxious responses in rats
20. The effect of substantia nigra stimulation and morphine on α‐motorneurones and the tail flick response
21. Modification of antinociceptive action of morphine by dopamine agonist and antagonists in mice. Japan
22. Effects of apomorphine on morphine analgesia during the state of dopaminergic supersensitivity after chronic treatment with haloperidol
23. The diagnosis of Parkinson's disease
24. Acute locomotor effects of MPTP in mice and relationships with dopaminergic systems
25. Effect of pharmacological manipulations of dopamine metabolism on the dopaminergic neurotoxicity of MPTP im mice
26. Facilitation of hot‐plate response learning by pre‐ and post‐training naltrexone administration
27. Effects of systemic administration of 1‐methyl‐4–phenyl‐1, 2, 3, 6‐tetrahydropyridine to mice on tyrosine hydroxylase, 1–3, 4‐dihydroxyphenylalanine decarboxylase, dopamine β‐hydroxylase, and monoamine oxidase activities in the striatum and hypothalamus
28. Morphine in the VTA and ventral striatum produces analgesia in the formalin test
29. Influence of 6‐hydroxydopamine on the effect of morphine on the tail flick latency
30. Sensory symptoms in parkinsonism related to central dopaminergic function
31. A study of the connections of nociceptive substantia nigra neurones
32. Studies on the acute and long‐term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP)
33. Pain in Parkinson's disease
34. Defeat, learned submissiveness, and analgesia in mice: effect of genotype
35. Primary sensory symptoms in parkinsonism
36. Acute electrophysiological and neurochemical effects of administration of MPTP in mice
37. Studies on the effect of 1‐methyl‐4–phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP) on central cathecolamine neurons in C57 BL/6 mice. Comparison with three other strains of mice
38. An improved method for tail‐flick testing with adjustment for tail‐skin temperature
39. Acute stress or neuroleptics elicit sensorimotor deficits in MPTP‐treated mice